; PET and Proliferation Monitoring
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

PET and Proliferation Monitoring

VIEWS: 2 PAGES: 1

Shields et al. from Wayne State University (Detroit, MI) reported in the July 15 issue of Clinical Cancer Research (2008;14:4463-4468) on methods to assess the reproducibility of measurement of fluorothymidine (FLT) retention in patients with nonsmall cell lung cancer (NSCLC), as part of a larger effort to apply ^sup 18^F-FLT PET in monitoring antineoplastic therapy.

More Info
To top
;